Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award

<div class="b2iNewsItemSubheadDiv">Frost &amp; Sullivan recognizes Adial for its best practices in precision medicine for the addiction disorders industry</div><div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify">CHARLOTTESVILLE, Va., Oct. 18, 2023 (GLOBE NEWSWIRE) -- <strong>Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) ("Adial" or the "Company"),</strong> a clinical-stage biopharmaceutical company...